| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/29/2009 | CN100482277C Calicheamicin derivative-carrier conjugates |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482275C Solidified tissue immunological adjuvant |
| 04/29/2009 | CN100482274C B-type hepatitis and E-type hepatitis combined vaccine and preapring method |
| 04/29/2009 | CN100482273C Capsular polysaccharide solubilisation and combination vaccines |
| 04/28/2009 | US7524947 Recombinant viral-based malaria vaccines |
| 04/28/2009 | US7524946 Isolated nucleic encoding antigenic proteins derived from Sarcocystis neurona, and sequences fully complementary to it; vectors comprising the nucleic acids |
| 04/28/2009 | US7524930 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 04/28/2009 | US7524927 Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524675 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 04/28/2009 | US7524663 immunogens and epitopes used for treatment of autoimmune diseases; catalytic antibodies |
| 04/28/2009 | US7524651 Marek's disease virus; genetic material derived from feathers is tested for the presence of genetic material from virus |
| 04/28/2009 | US7524650 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 04/28/2009 | US7524635 Using hormone peptides concentrations as diagnostic tools in detection of cardiovascular disorders |
| 04/28/2009 | US7524628 Method for detecting molecules expressing a selected epitope via fluorescent dyes |
| 04/28/2009 | US7524627 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus |
| 04/28/2009 | US7524624 Using druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins; viral fusion inhibitors |
| 04/28/2009 | US7524622 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
| 04/28/2009 | US7524510 Alkyl-glycoside enhanced vaccination |
| 04/28/2009 | US7524509 Proteosome-liposaccharide vaccine adjuvant |
| 04/28/2009 | US7524508 Contain large deletions; vaccines against dengue virus infection; structural proteins encapsulate said subgenomic replicon |
| 04/28/2009 | US7524507 Enhancing expression of protein in gsstrointestinal mucosal cells of mammal by placing in recombinant gut-colonizing bacterium (Salmonella), attenuated so mammal does not experience significant harmful infectious effects; vaccines |
| 04/28/2009 | US7524506 gM-negative EHV-mutants without heterologous elements |
| 04/28/2009 | US7524503 Antigens; vaccines; isolated peptide |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |
| 04/28/2009 | US7524501 Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies |
| 04/28/2009 | US7524500 Method of stimulating stem cells |
| 04/28/2009 | US7524498 Human immunomodulatory monoclonal antibodies for the treatment of cancer |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/28/2009 | US7524495 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation |
| 04/28/2009 | CA2212382C Cochleate delivery vehicles |
| 04/28/2009 | CA2123227C Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| 04/28/2009 | CA1341595C Procedure for obtaining dna, rna, peptides, polypeptides, or proteins byrecombinant dna techniques |
| 04/23/2009 | WO2009052454A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 04/23/2009 | WO2009052439A2 Immunotherapy regimes dependent on apoe status |
| 04/23/2009 | WO2009052431A2 Cd19 binding agents and uses thereof |
| 04/23/2009 | WO2009052379A2 Improved antitumoral treatments |
| 04/23/2009 | WO2009052376A1 Methods for the diagnosis of genitourinary cancer |
| 04/23/2009 | WO2009052374A2 Igm-mediated receptor clustering and cell modulation |
| 04/23/2009 | WO2009052328A1 Use of mva to treat prostate cancer |
| 04/23/2009 | WO2009052293A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/23/2009 | WO2009052211A1 Compositions and methods for enhancing lymphangiogenesis |
| 04/23/2009 | WO2009052140A1 Use of tnf receptor antagonists for treating dry eye |
| 04/23/2009 | WO2009052125A2 Human anti-amyloid antibodies, compositions, methods and uses |
| 04/23/2009 | WO2009052081A2 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/23/2009 | WO2009051992A1 Compositions and methods for treating diseases involving ocular angiogenesis by inhibiting one or more selected receptor tyrosine kinases |
| 04/23/2009 | WO2009051974A1 Antibodes to cll-1 |
| 04/23/2009 | WO2009051957A2 Antibodies to irem-1 |
| 04/23/2009 | WO2009051840A2 Compositions and methods for reducing hepatotoxicity associated with drug administration |
| 04/23/2009 | WO2009051837A2 Vaccine nanotechnology |
| 04/23/2009 | WO2009051823A2 Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof |
| 04/23/2009 | WO2009051797A1 Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
| 04/23/2009 | WO2009051628A2 Transdermal treatment device and method |
| 04/23/2009 | WO2009051555A2 Modified mhc class i binding peptides |
| 04/23/2009 | WO2009051265A2 Stabilisation of antibodies on hazardous subtance-removing material and method of removing hazardous substances |
| 04/23/2009 | WO2009051238A1 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof |
| 04/23/2009 | WO2009051220A1 Antibody capable of specifically binding to aβ oligomer, and use thereof |
| 04/23/2009 | WO2009051201A1 Anti-bst2 antibody |
| 04/23/2009 | WO2009050898A1 Therapeutic agent for colorectal cancer |
| 04/23/2009 | WO2009050691A2 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 04/23/2009 | WO2009050586A1 Meningococcal vaccine formulations |
| 04/23/2009 | WO2009050446A1 Viral therapeutic |
| 04/23/2009 | WO2009050403A2 Patch with hydrophilic adhesive |
| 04/23/2009 | WO2009050390A2 Method for producing flu virus |
| 04/23/2009 | WO2009050388A1 Antibody against anthrax toxins |
| 04/23/2009 | WO2009050282A1 Tr1 cells, mesenchymal stem cells and uses thereof |
| 04/23/2009 | WO2009050143A1 Combinations of (1r, 2r, 3s, 4s) -n4- (3-aminocarbonylbicyclo [2. 2. 1] hept-5-ene-2-yl) - 5-fluoro-n2- [ ( 3 - methyl-4- (4 -methylpiperazin-1-yl] phenyl-2, 4-pyrimidineamine |
| 04/23/2009 | WO2009049841A1 Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
| 04/23/2009 | WO2009049406A1 Use of ps20 /wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | WO2009018122A3 Methods and compositions for increasing alpha-iduronidase activity in the cns |
| 04/23/2009 | WO2009009019A3 Treatment and diagnostic methods for fibrosis related disorders |
| 04/23/2009 | WO2009002939A3 Autophilic antibodies |
| 04/23/2009 | WO2009000098A3 Sequence based engineering and optimization of single chain antibodies |
| 04/23/2009 | WO2008151633A3 Vectors for vaccines against lentivirus infections |
| 04/23/2009 | WO2008143708A3 Methods and materials related to anti-amyloid antibodies |
| 04/23/2009 | WO2008134659A8 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 04/23/2009 | WO2008109440A3 Predicting response to a her dimerisation inhibitor based on low her3 expression |
| 04/23/2009 | WO2008055072A3 Compositions and methods for treating ocular diseases and conditions |
| 04/23/2009 | WO2008021353A3 Composition and method for controlling hepatitis c virus infection |
| 04/23/2009 | WO2007146172A8 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 04/23/2009 | WO2007144893A3 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 04/23/2009 | WO2007115148A3 Human mimetic epo hinge core mimetibodies |
| 04/23/2009 | WO2007046893A3 Methods for generating bioactive assemblies and uses thereof |
| 04/23/2009 | WO2007044450A3 Compositions and methods for the treatment of cancer |
| 04/23/2009 | WO2007037669A3 Compositions for prevention and treatment of infections caused by eimeria parasites in animals |
| 04/23/2009 | WO2007032804A3 Novel uses for anti-ige therapy |
| 04/23/2009 | WO2007014311A3 Composition permitting muscle growth while protecting joint health |
| 04/23/2009 | WO2007009064A3 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/23/2009 | WO2007005786A3 Methods and compositions with enhanced therapeutic activity |
| 04/23/2009 | WO2006133450A3 Anti-cd19 antibody therapy for the transplantation |
| 04/23/2009 | WO2006113907A3 Escherichia coli o157:h7 proteins and uses thereof |
| 04/23/2009 | WO2006112879A3 Hunk, a snf1-related kinase essential for mammary tumor metastasis |
| 04/23/2009 | WO2006107387A3 Wound treatment device for photodynamic therapy and method of using same |
| 04/23/2009 | WO2006086561A3 Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus |
| 04/23/2009 | WO2006076467A3 Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| 04/23/2009 | WO2005121179A3 Transferrin receptor antibodies |
| 04/23/2009 | WO2005032399A3 Il4 receptor antagonists for horse, dog and cat |
| 04/23/2009 | WO2004028479A9 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/23/2009 | US20090106864 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin |